Return to QS149 Overview

Osteoporosis [QS149]

Measuring the use of this guidance

Statement: 1

Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.

Quality standard measure: Proportion of adults who have had a fragility fracture who have an assessment of their fracture risk.
What was measured: Proportion of patients aged 50-74 years who had sustained a fragility fracture who had a DXA scan ordered or recommended, or had undergone a DXA in the previous 2 years.
Data collection end: December 2016
68%
Area covered: England
Source: Royal College of Physicians. Fracture Liaison Service Database (FLS-DB) Facilities audit


Statement: 2

Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.

Quality standard measure: Proportion of adults at high risk of fragility fracture receiving drug treatment to reduce fracture risk.
What was measured: Proportion of patients aged 50 years and over who had sustained a fragility fracture and for whom anti-osteoporosis medication was recommended who were on treatment within the first 4 months.
Data collection end: December 2016
13%
Area covered: England and Wales
Source: Royal College of Physicians. Fracture Liaison Service Database (FLS-DB) clinical audit

Quality standard measure: Proportion of adults at high risk of fragility fracture receiving drug treatment to reduce fracture risk.
What was measured: Proportion of patients aged 50 years and over who had sustained a fragility fracture and had a recorded treatment outcome who were recommended for bone therapy.
Data collection end: December 2016
23%
Area covered: England and Wales
Source: Royal College of Physicians. Fracture Liaison Service Database (FLS-DB) clinical audit



 Return to QS149 Overview